3 days popular7 days popular1 month popular3 months popular

Cancer cells hide from the immune system in tumor microenvironment

is aided by the ability of tumors to evade recognition by the .

In this issue of the , and colleagues at identify a mechanism by which tumors evade detection. Using mouse models of breast cancer and melanoma, they show that loss of the Type III TGF-β receptor (TGFBR3) in tumors promotes cancer progression by altering signaling in tumor-associated immune cells.

This study supports the use of TGF-β inhibitors to enhance the efficacy of therapies that promote immune-mediated elimination of tumor cells.

TITLE: Type III TGF-β receptor downregulation generates and immunotolerant tumor microenvironment


Journal of Clinical Investigation